Cerebrolysin Research & Studies
We track 20 published, PubMed-indexed studies for Cerebrolysin, spanning 2013 to 2025. The research below includes 1 clinical trial, 7 reviews, 12 meta-analysiss.
These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
1
Clinical Trial
7
Reviews
12
Meta-Analysiss
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study.
Clinical TrialHomberg V, Jianu DC, et al.|Stroke|2025
The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts.
ReviewAl-Kuraishy HM, Al-Gareeb AI, et al.|Neuroscience|2025
[Cerebrolysin as an early add-on to reperfusion therapy: heterogeneous treatment effect analysis in ischemic stroke patients with varying risk of hemorrhagic transformation].
Meta-AnalysisKalinin MN, Khasanova DR|Zh Nevrol Psikhiatr Im S S Korsakova|2024
Efficacy, safety, and cost-effectiveness analysis of Cerebrolysin in acute ischemic stroke: A rapid health technology assessment.
ReviewWan M, Yang K, et al.|Medicine (Baltimore)|2024
Cerebrolysin for acute ischaemic stroke.
ReviewZiganshina LE, Abakumova T, et al.|Cochrane Database Syst Rev|2023
Nanowired Delivery of Cerebrolysin Together with Antibodies to Amyloid Beta Peptide, Phosphorylated Tau, and Tumor Necrosis Factor Alpha Induces Superior Neuroprotection in Alzheimer's Disease Brain Pathology Exacerbated by Sleep Deprivation.
ReviewSharma A, Feng L, et al.|Adv Neurobiol|2023
Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series.
Meta-AnalysisVester JC, Buzoianu AD, et al.|Neurol Sci|2021
Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes.
ReviewFiani B, Covarrubias C, et al.|Neurol Sci|2021
Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use.
ReviewGavrilova SI, Alvarez A|Med Res Rev|2021
Neuroprotective strategies of cerebrolysin for the treatment of infants with neonatal hypoxic-ischemic encephalopathy.
ReviewFiani B, Chacon D, et al.|Acta Neurol Belg|2021
Cerebrolysin for acute ischaemic stroke.
Meta-AnalysisZiganshina LE, Abakumova T, Hoyle CH|Cochrane Database Syst Rev|2020
Cerebrolysin for vascular dementia.
Meta-AnalysisCui S, Chen N, et al.|Cochrane Database Syst Rev|2019
Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials.
Meta-AnalysisBornstein NM, Guekht A, et al.|Neurol Sci|2018
Cerebrolysin for acute ischaemic stroke.
Meta-AnalysisZiganshina LE, Abakumova T, Vernay L|Cochrane Database Syst Rev|2017
Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials.
Meta-AnalysisWang Z, Shi L, et al.|Drug Des Devel Ther|2017
Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials.
Meta-AnalysisGuekht A, Vester J, et al.|Neurol Sci|2017
Cerebrolysin for acute ischaemic stroke.
Meta-AnalysisZiganshina LE, Abakumova T, Vernay L|Cochrane Database Syst Rev|2016
Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials.
Meta-AnalysisGauthier S, Proaño JV, et al.|Dement Geriatr Cogn Disord|2015
Cerebrolysin for vascular dementia.
Meta-AnalysisChen N, Yang M, et al.|Cochrane Database Syst Rev|2013
[Cerebrolysin for acute ischemic stroke].
Meta-Analysisiganshina LE, Abakumova TR|Vestn Ross Akad Med Nauk|2013